Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Hester

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Drug Safety and Regulation|September 22, 2025
Editorial: External control arms for single-arm studies: methodological considerations and applicationsDeborah Layton, Laura Hester, Asieh Golozar
Pharmacoepidemiology and Drug Safety|November 26, 2025
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator ArmDaniel Backenroth, Laura Hester, Stijn Vansteelandt
Journal of Studies on Alcohol and Drugs|November 5, 2011
Social network characteristics and heavy episodic drinking among women at risk for HIV/sexually transmitted infectionsMelissa A Davey-Rothwell, Geetanjali Chander, Laura Hester, et al.
Annals of the Association of American Geographers. Association of American Geographers|April 30, 2013
An examination of spatial concentrations of sex exchange and sex exchange norms among drug users in Baltimore, MarylandKarin Elizabeth Tobin, Laura Hester, Melissa Ann Davey-Rothwell, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studiesChinenye Ugoji, Julien Heidt, Joan Largent, et al.
Cancer Medicine|July 19, 2025
Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple MyelomaJessie Sutphin, Thomas W LeBlanc, Ellen Janssen, et al.
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Real-world patient profile and step-up dosing process of early initiators of teclistamab for multiple myeloma in US hospitals: An analysis using the Premier Healthcare DatabaseCarlyn Rose Tan, Eric Chinaeke, Nina Kim, et al.
American Journal of Hematology|July 5, 2023
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry dataEli Silvert, Laura Hester, Eshwan Ramudu, et al.
Current Medical Research and Opinion|April 28, 2020
Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database studyZhong Yuan, Frank DeFalco, Lu Wang, et al.
Pharmacology Research & Perspectives|November 2, 2024
Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapyScott F Huntington, Dee Lin, Marie-Hélène Lafeuille, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Drug Safety and Regulation|September 22, 2025
Editorial: External control arms for single-arm studies: methodological considerations and applicationsDeborah Layton, Laura Hester, Asieh Golozar
Pharmacoepidemiology and Drug Safety|November 26, 2025
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator ArmDaniel Backenroth, Laura Hester, Stijn Vansteelandt
Journal of Studies on Alcohol and Drugs|November 5, 2011
Social network characteristics and heavy episodic drinking among women at risk for HIV/sexually transmitted infectionsMelissa A Davey-Rothwell, Geetanjali Chander, Laura Hester, et al.
Annals of the Association of American Geographers. Association of American Geographers|April 30, 2013
An examination of spatial concentrations of sex exchange and sex exchange norms among drug users in Baltimore, MarylandKarin Elizabeth Tobin, Laura Hester, Melissa Ann Davey-Rothwell, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studiesChinenye Ugoji, Julien Heidt, Joan Largent, et al.
Cancer Medicine|July 19, 2025
Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple MyelomaJessie Sutphin, Thomas W LeBlanc, Ellen Janssen, et al.
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Real-world patient profile and step-up dosing process of early initiators of teclistamab for multiple myeloma in US hospitals: An analysis using the Premier Healthcare DatabaseCarlyn Rose Tan, Eric Chinaeke, Nina Kim, et al.
American Journal of Hematology|July 5, 2023
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry dataEli Silvert, Laura Hester, Eshwan Ramudu, et al.
Current Medical Research and Opinion|April 28, 2020
Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database studyZhong Yuan, Frank DeFalco, Lu Wang, et al.
Pharmacology Research & Perspectives|November 2, 2024
Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapyScott F Huntington, Dee Lin, Marie-Hélène Lafeuille, et al.
Pageof 2